Effects of Steroids and Malignancy on Bone Health
Author Information
Author(s): Asayag Keren, Peled Eli, Assalia Mai, Crispel Yonatan, Yanovich Chen, Cohen Haim, Keren-Politansky Anat, Nadir Yona
Primary Institution: Rambam Health Care Campus
Hypothesis
How do steroids and malignancy affect coagulation factors and osteoblast activity in bone tissue?
Conclusion
Steroids and malignancy increase coagulation system activation in bone microcirculation while reducing osteoblast activity.
Supporting Evidence
- Dexacort and malignant medium significantly increased heparanase levels in osteoblasts.
- ALKP levels, indicating osteoblast activity, significantly decreased under dexacort or malignant medium conditions.
- Peptide 16AC further increased heparanase levels and decreased ALKP levels in osteoblasts.
- Peptide 6 inhibited the increase of heparanase and restored ALKP levels in osteoblasts.
- Mice treated with dexacort showed increased coagulation parameters and decreased osteoblast activity.
- Human bone biopsies showed dilated blood vessels and increased heparanase levels in the study group.
Takeaway
This study found that steroids and cancer can harm bones by increasing certain proteins that cause blood clots and decreasing the activity of bone-building cells.
Methodology
The study involved human bone biopsies and mouse models to evaluate the effects of steroids and malignant conditions on heparanase levels and osteoblast activity.
Limitations
The study only evaluated the effect of dexacort and included limited types of malignant cell lines.
Participant Demographics
40 patients: 10 with bone metastasis, 10 with steroid-induced avascular necrosis, 10 with osteoarthritis, and 10 controls.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website